PDS Biotechnology Corporation PDSB
Set alert
1.51 USD +0.14 +10.22%
As of Nov 3, 2:19 PM ET
1.35 Day range 1.53
0.195 52-week range 1.79
- YTD
- +96.10%
- 1 year
- +61.67%
- Open
- 1.35
- Prev close
- 1.37
- Mkt cap
- 158.55M
- Vol
- 3.85M
- Avg vol
- 25.63M
- EPS
- -0.64
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.35
- High
- 1.53
- Forward P/E
- -1.18
- Beta
- 1.93
- Short ratio
- 10.47
- Inst. own
- 12.36%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.60
- 200-d avg
- 3.22
- 1y target
- 11.50
MAX chart
Events in this range
- Oct 2, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (32)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| MACD: Buy Signal | Jun 1, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 1, 2024 | 1 year ago |
| MACD: Buy Signal | Sep 1, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 1, 2024 | 2 years ago |
| SMA: Bearish | Mar 1, 2024 | 2 years ago |
| SMA: Bullish | Feb 1, 2024 | 2 years ago |
| SMA: Bearish | Jun 1, 2023 | 3 years ago |
| SMA: Bearish | Jun 1, 2023 | 3 years ago |
| SMA: Bullish | May 1, 2023 | 3 years ago |
| SMA: Bullish | May 1, 2023 | 3 years ago |
| SMA: Bearish | Mar 1, 2023 | 3 years ago |
| SMA: Bearish | Mar 1, 2023 | 3 years ago |
| SMA: Bullish | Nov 1, 2022 | 4 years ago |
| SMA: Bullish | Oct 1, 2022 | 4 years ago |
| SMA: Bearish | May 1, 2022 | 4 years ago |
| SMA: Bearish | Nov 1, 2021 | 5 years ago |
| SMA: Bullish | Mar 1, 2021 | 5 years ago |
Newest 20 of 32.
Financial health
Altman Z-Score
-44.34 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -1.0×
FY 2016 5y median -3.6× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 3.9×
FY 2016 5y median 3.9× FY 2025
P/FCF -1.3×
FY 2016 5y median -4.6× FY 2025
EV/EBITDA -0.9×
FY 2016 5y median -3.1× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -77.7%
FY 2016 5y median -21.9% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -372.9%
FY 2016 5y median -164.3% FY 2025
ROIC -116.5%
FY 2016 5y median -83.4% FY 2025
ROA -113.1%
FY 2016 5y median -72.3% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 13.2%
FY 2016 FY 2025
EPS (diluted) 28.2%
FY 2016 FY 2025
Free Cash Flow 20.8%
FY 2016 FY 2025
Financial Health
Current Ratio 3.0×
FY 2016 5y median 4.3× FY 2025
Quick Ratio 3.0×
FY 2016 5y median 4.3× FY 2025
Debt / Equity 1.8×
FY 2016 5y median 0.9× FY 2025
Net Debt / EBITDA 0.3×
FY 2016 5y median 1.2× FY 2025
Interest Coverage -5.9×
FY 2016 5y median -7.8× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
